These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9455791)

  • 21. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
    Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
    Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
    Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
    Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
    Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH; Duan JX; Vu TH; Hoffman AR
    J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.
    Grbesa I; Marinkovic M; Ivkic M; Kruslin B; Novak-Kujundzic R; Pegan B; Bogdanovic O; Bedekovic V; Gall-Troselj K
    J Mol Med (Berl); 2008 Sep; 86(9):1057-66. PubMed ID: 18604514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
    Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
    Rainho CA; Kowalski LP; Rogatto SR
    Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M; Seeger RC; Mizoguchi H; Koeffler HP
    Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19.
    Hu JF; Vu TH; Hoffman AR
    J Biol Chem; 1997 Aug; 272(33):20715-20. PubMed ID: 9252392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
    Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
    Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Igf2 imprinting does not require its own DNA methylation or H19 RNA.
    Jones BK; Levorse JM; Tilghman SM
    Genes Dev; 1998 Jul; 12(14):2200-7. PubMed ID: 9679064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
    Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
    J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer].
    Kondo M; Takahashi T
    Nihon Rinsho; 1996 Feb; 54(2):492-6. PubMed ID: 8838103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
    Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
    Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.